Analyst coverage
Oxford Instruments plc is followed regularly, principally by the analysts listed below.
JP Morgan Cazenove
Lushanthan Mahendrarajah
Deutsche Numis
Richard Paige
Peel Hunt
Andrew Humphrey
Shore Capital
Akhil Patel
Average of forecasts submitted by our covering analysts
| 2025 actual | | 2026 estimate | |
| Actual adjusted figures | Minimum | Mean | Maximum |
Revenue | £500.6m | £409.8m | £439.9m | £455.0m |
EBIT (Adj) | £82.2m | £70.7m | £78.4m | £81.0m |
EPS (Adj/diluted) | 111.1p | 93.6p | 104.3p | 109.1p |
Net cash | £84.4m | £69.6m | £115.9m | £138.4m |
Notes
1. The above results are on an adjusted basis, described in the glossary to Full Year and Interim results and considered by the Board to be a key measure of performance.
2. Consensus updated on 31 July 2025 and includes estimates from six of our seven covering analysts who have updated numbers following the announcement of the forthcoming sale of our NanoScience quantum business. The NanoScience business is included in the 2025 actual results.
Disclaimer
Oxford Instruments plc is followed regularly principally by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Oxford Instruments plc performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oxford Instruments plc or its management. Oxford Instruments plc does not endorse or express any opinion on the information, conclusions or recommendations of any of the above analysts.
No assurance is given that the above list is current or complete and it may change from time to time as analysts change their coverage. Oxford Instruments plc undertakes no obligation to update this list. Oxford Instruments plc does not distribute information or reports prepared by analysts.
The consensus above is an average of forecasts that have been provided to Oxford Instruments by a number of research analysts who cover the Company. The consensus includes key indicators only and does not purport to be comprehensive. The consensus figures are not based on Oxford Instruments’ own opinions, estimates or forecasts and Oxford Instruments has not endorsed, commented on or verified the consensus information or any of the underlying forecasts, nor does it intend to do so. It should be noted that these forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Oxford Instruments is not regulated by the Financial Conduct Authority and cannot offer investment advice. The consensus figures are provided for information purposes only and are not intended to, nor do they, constitute investment advice or any recommendation to buy or sell shares in Oxford Instruments or to take any other action or place any reliance on the analysis.
Oxford Instruments makes no warranty or representation, express or implied, as to the accuracy, completeness or achievability of the consensus figures. Neither Oxford Instruments nor any subsidiary undertaking or any director, officer or employee of Oxford Instruments accepts, to the fullest extent permitted by law, any responsibility for the accuracy, completeness or achievability of the consensus figures and therefore the foregoing shall, to the fullest extent permitted by law, have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in the consensus figures.
Oxford Instruments will endeavour to update, revise or supplement this information to reflect circumstances existing after the date the consensus figures are published but assumes no obligation to do so.
The consensus figures do not take into consideration the investment objectives, financial situation or particular needs of any particular investor. Before making an investment decision, a prospective investor should consider its particular investment needs, objectives and financial circumstances, and should seek appropriate professional advice, tailored to the investor's circumstances. Any investment in securities is subject to investment risks.
The provision of consensus figures by Oxford Instruments is not mandatory and Oxford Instruments may change its practice on this at any time.